CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...

Within the paediatric age group with access to vaccines, cumulative rates of Covid-19-associated hospitalisations were ...

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Moderna said it's planning to submit a request to the U.S. Food and Drug Administration to authorize a low-dose COVID-19 vaccine for children under 6 years old, part of a push to inoculate the 18 ...

Moderna is backing the American Lung Association’s (ALA’s) call for people with lung diseases to get vaccinated for the ...

Moderna is asking U.S. regulators to allow for use of its COVID-19 vaccine on the nation's youngest children. Moderna submitted data to the Food and Drug Administration Thursday for emergency use ...

Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

A key question for investors going forward will be whether Moderna's other latent virus vaccines for Epstein-Barr and ...